Pfizer

News

Pfizer strikes $1.2bn licensing deal for Biohaven migraine d...

Pfizer has bolstered its central nervous system (CNS) drugs portfolio with a $1.2 billion deal to claim rights outside the US to Biohaven's Nurtec ODT, an oral therapy for migraine.

News

Pfizer's pill cuts COVID deaths and hospitalisations by 90%

An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or death from COVID-19 when given in the early stages of infection.

News

Pharma group will develop 'digital endpoint' for atopic derm...

The development of digital medicine requires valid endpoints that can be used in clinical trials, and a consortium of pharma companies has just identified a new one for atopic dermatitis.

News

US backs COVID jabs for young kids – should others follow?

The US is now pressing ahead with plans to extend its COVID-19 vaccination campaign to younger children aged five and over, prompting a debate about the policy in other countries.<

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Pfizer's COVID jab sales swell again, with $36bn forecast fo...

Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once again to a whopping $36 billion, more than double its predictions just a

News

FDA delays review of Moderna COVD jab in adolescents

The FDA has said it needs more time to review Moderna's application for emergency use of its COVID-19 vaccine mRNA-1273 in children aged 12 to 17, as it looks at data on heart inflammation

Pfizer strikes $1.2bn licensing deal for Biohaven migraine d...

Pfizer's pill cuts COVID deaths and hospitalisations by 90%

Pharma group will develop 'digital endpoint' for atopic derm...

US backs COVID jabs for young kids – should others follow?

Pfizer's COVID jab sales swell again, with $36bn forecast fo...

FDA delays review of Moderna COVD jab in adolescents

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks